Clinical trial
SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors
NCT00015899 · Pediatric Brain Tumor Consortium, Other · Completed
Key facts
| NCT number | NCT00015899 |
|---|---|
| Title | SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors |
| Official title | Phase I Trial Of Escalating Oral Doses Of SCH 66336 In Pediatric Patients With Refractory Or Recurrent Brain Tumors |
| Lead sponsor | Pediatric Brain Tumor Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Drug |
| Interventions | lonafarnib |
| Enrollment | 53 |
| Start date | Jan 1, 2002 |
| Primary completion | Sep 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 14, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: